Chronic respiratory diseases such as chronic obstructive pulmonary disease and asthma are on the rise in many countries, including low-income and middle-income countries such as Kenya that also have a sizeable burden of tuberculosis. What does this mean for patients in terms of the affordability of potentially long-term management? How are government-run social health insurance schemes working for individuals and their families? And what might be the individual-level drivers of catastro...
All content for The Lancet Global Health in conversation with is the property of The Lancet Group and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Chronic respiratory diseases such as chronic obstructive pulmonary disease and asthma are on the rise in many countries, including low-income and middle-income countries such as Kenya that also have a sizeable burden of tuberculosis. What does this mean for patients in terms of the affordability of potentially long-term management? How are government-run social health insurance schemes working for individuals and their families? And what might be the individual-level drivers of catastro...
Senjuti Saha on the health-care burden of RSV in Bangladesh
The Lancet Global Health in conversation with
21 minutes
2 weeks ago
Senjuti Saha on the health-care burden of RSV in Bangladesh
In a resource-constrained setting like Bangladesh, what proportion of a hospital's capacity is taken up with admissions for respiratory syncytial virus (RSV)? How many children needing admission are turned away every year because of lack of bed space? And how many of these "denials" and subsequent deaths might be prevented by the introduction of a maternal RSV vaccine or the monoclonal antibody nirsevimab? Listen to Senjuti Saha, Deputy Executive Director of the Child Health Research Fo...
The Lancet Global Health in conversation with
Chronic respiratory diseases such as chronic obstructive pulmonary disease and asthma are on the rise in many countries, including low-income and middle-income countries such as Kenya that also have a sizeable burden of tuberculosis. What does this mean for patients in terms of the affordability of potentially long-term management? How are government-run social health insurance schemes working for individuals and their families? And what might be the individual-level drivers of catastro...
